QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
QQQ   359.07 (+0.30%)
AAPL   171.27 (+0.34%)
MSFT   317.05 (+1.09%)
META   303.33 (-0.21%)
GOOGL   131.64 (-0.51%)
AMZN   127.32 (+1.06%)
TSLA   250.94 (+1.85%)
NVDA   436.03 (+1.19%)
NIO   9.04 (+1.46%)
BABA   86.86 (+1.54%)
AMD   103.50 (+0.72%)
T   14.97 (-0.27%)
F   12.49 (-0.56%)
MU   67.76 (+3.93%)
CGC   0.80 (-2.22%)
GE   110.34 (-1.78%)
DIS   80.71 (+0.72%)
AMC   8.10 (+3.98%)
PFE   33.01 (+2.87%)
PYPL   58.40 (+0.38%)
NFLX   376.74 (+0.10%)
NASDAQ:ZIMV

ZimVie (ZIMV) Stock Forecast, Price & News

$9.30
-0.14 (-1.48%)
(As of 01:07 PM ET)
Compare
Today's Range
$9.30
▼
$9.58
50-Day Range
$9.20
▼
$14.12
52-Week Range
$5.05
▼
$15.50
Volume
45,285 shs
Average Volume
455,522 shs
Market Capitalization
$246.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

ZimVie MarketRank™ Forecast

Analyst Rating
Sell
1.00 Rating Score
Upside/​Downside
17.3% Upside
$11.00 Price Target
Short Interest
Healthy
2.72% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.67mentions of ZimVie in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
32.81%
From $0.64 to $0.85 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.80 out of 5 stars

Medical Sector

800th out of 970 stocks

Dental Equipment & Supplies Industry

4th out of 4 stocks

See Top Rated MarketRank™ Stocks Here

ZIMV stock logo

About ZimVie (NASDAQ:ZIMV) Stock

ZimVie Inc., a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; hardware and software solutions consist of intraoral scanners and RealGUIDE; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZIMV Price History

ZIMV Stock News Headlines

September 29, 2023 | americanbankingnews.com
ZimVie Inc. (NASDAQ:ZIMV) Sees Significant Increase in Short Interest
September 26, 2023 | markets.businessinsider.com
ZimVie: FDA Allows To Move Forward With Mobi-C Hybrid Study - Quick Facts
September 29, 2023 | PressReach (Ad)
This Stock's a Sleeping Giant
The stock everyone has their eye on - discover why it's the talk of the investment world.
September 26, 2023 | finance.yahoo.com
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
September 11, 2023 | finance.yahoo.com
Here’s Why ZimVie (ZIMV) Advanced in Q2
September 8, 2023 | fool.com
ZimVie (NASDAQ: ZIMV)
August 31, 2023 | msn.com
ZimVie (ZIMV) Price Target Increased by 57.14% to 11.22
August 17, 2023 | msn.com
ZimVie expands cooperation with Brainlab on systems compatibility, co-marketing
September 29, 2023 | PressReach (Ad)
This Stock's a Sleeping Giant
The stock everyone has their eye on - discover why it's the talk of the investment world.
August 17, 2023 | finance.yahoo.com
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
August 11, 2023 | msn.com
FDA approves smaller height of Mobi-C artificial discs for cervical replacement
August 10, 2023 | msn.com
ZimVie gains on FDA nod for new Mobi-C cervical disc implant
August 10, 2023 | finance.yahoo.com
ZimVie Announces FDA Approval for New Mobi-C® Implant
August 10, 2023 | finance.yahoo.com
Why Fast-paced Mover ZimVie Inc. (ZIMV) Is a Great Choice for Value Investors
August 8, 2023 | markets.businessinsider.com
Barclays Maintains Underweight Rating for ZimVie: Here's What You Need To Know
August 6, 2023 | finance.yahoo.com
Investors in ZimVie (NASDAQ:ZIMV) have unfortunately lost 35% over the last year
August 3, 2023 | finance.yahoo.com
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
July 15, 2023 | news.yahoo.com
Hampton Roads residents come in droves for much-needed care at free pop-up clinic
July 12, 2023 | finance.yahoo.com
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
June 21, 2023 | msn.com
ZimVie: Downgrade To A Hold On Valuation And Fundamentals
June 2, 2023 | finance.yahoo.com
Here’s Why ZimVie (ZIMV) Declined in Q1
May 22, 2023 | finance.yahoo.com
ZimVie to Present at the Stifel 2023 Jaws & Paws Conference
May 12, 2023 | msn.com
ZimVie's Return On Capital Employed Insights
May 9, 2023 | marketwatch.com
Dental Allograft Bone Material Market Expectation Surges with Rising Demand With Top Companies | Cowellmedi, ZimVie Inc, Straumann
May 9, 2023 | msn.com
Barclays Maintains ZimVie (ZIMV) Underweight Recommendation
May 4, 2023 | benzinga.com
ZimVie shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results.
May 4, 2023 | finance.yahoo.com
Q1 2023 ZimVie Inc Earnings Call
See More Headlines
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Company Calendar

Last Earnings
8/02/2023
Today
9/29/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZIMV
CUSIP
N/A
CIK
1876588
Web
www.zimvie.com
Phone
303-443-7500
Fax
N/A
Employees
2,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.00
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+17.0%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($3.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
14.69
P/E Growth
N/A
Net Income
$-63,880,000.00
Net Margins
-9.27%
Pretax Margin
-11.94%
Return on Equity
3.80%
Return on Assets
1.76%

Debt

Debt-to-Equity Ratio
0.74
Current Ratio
2.67
Quick Ratio
1.47

Sales & Book Value

Annual Sales
$913.86 million
Price / Sales
0.27
Cash Flow
$6.67 per share
Price / Cash Flow
1.41
Book Value
$29.08 per share
Price / Book
0.32

Miscellaneous

Outstanding Shares
26,530,000
Free Float
25,731,000
Market Cap
$249.38 million
Optionable
Not Optionable
Beta
1.40
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Vafa Jamali (Age 53)
    Pres, CEO & Director
    Comp: $1.41M
  • Mr. Richard J. Heppenstall (Age 52)
    Exec. VP, CFO & Treasurer
    Comp: $749.83k
  • Mr. Indraneel Kanaglekar (Age 45)
    Sr. VP & Pres of Global Dental
    Comp: $534.5k
  • Ms. Rebecca A. Whitney (Age 46)
    Sr. VP & Pres of Global Spine
    Comp: $622.97k
  • Mr. Benjamin Hutson
    Sr. VP of Operations
  • Sandra Schneider
    Chief Accounting Officer
  • Mr. Steve Rondeau
    Sr. VP & Chief Information Officer
  • Ms. Heather Kidwell (Age 54)
    Sr. VP, Chief Legal, HR & Compliance Officer and Corp. Sec.
  • Ms. Laura Driscoll
    VP of Communications
  • Mr. Michael Minette
    Sr. VP of Strategy & Corp. Devel.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ZIMV Stock - Frequently Asked Questions

Should I buy or sell ZimVie stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" ZIMV shares.
View ZIMV analyst ratings or view top-rated stocks.

What is ZimVie's stock price forecast for 2023?

1 brokerages have issued 1 year target prices for ZimVie's stock. Their ZIMV share price forecasts range from $11.00 to $11.00. On average, they anticipate the company's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 17.0% from the stock's current price.
View analysts price targets for ZIMV or view top-rated stocks among Wall Street analysts.

How have ZIMV shares performed in 2023?

ZimVie's stock was trading at $9.34 at the beginning of 2023. Since then, ZIMV stock has increased by 0.6% and is now trading at $9.40.
View the best growth stocks for 2023 here.

Are investors shorting ZimVie?

ZimVie saw a increase in short interest in September. As of September 15th, there was short interest totaling 705,400 shares, an increase of 37.7% from the August 31st total of 512,100 shares. Based on an average trading volume of 216,400 shares, the short-interest ratio is currently 3.3 days. Currently, 2.7% of the shares of the stock are short sold.
View ZimVie's Short Interest.

When is ZimVie's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our ZIMV earnings forecast.

How were ZimVie's earnings last quarter?

ZimVie Inc. (NASDAQ:ZIMV) posted its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.17 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.20. The business had revenue of $224.90 million for the quarter, compared to the consensus estimate of $212.36 million. ZimVie had a positive trailing twelve-month return on equity of 3.80% and a negative net margin of 9.27%.

What ETF holds ZimVie's stock ?

Schwab Ariel ESG ETF holds 1,617 shares of ZIMV stock, representing 0.08% of its portfolio.

What guidance has ZimVie issued on next quarter's earnings?

ZimVie issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $0.50-$0.70 for the period, compared to the consensus EPS estimate of $0.46. The company issued revenue guidance of $850.00 million-$870.00 million, compared to the consensus revenue estimate of $849.00 million.

What is ZimVie's stock symbol?

ZimVie trades on the NASDAQ under the ticker symbol "ZIMV."

How do I buy shares of ZimVie?

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ZimVie's stock price today?

One share of ZIMV stock can currently be purchased for approximately $9.40.

How much money does ZimVie make?

ZimVie (NASDAQ:ZIMV) has a market capitalization of $249.38 million and generates $913.86 million in revenue each year. The company earns $-63,880,000.00 in net income (profit) each year or ($3.16) on an earnings per share basis.

How many employees does ZimVie have?

The company employs 2,700 workers across the globe.

How can I contact ZimVie?

The official website for the company is www.zimvie.com. The company can be reached via phone at 303-443-7500 or via email at marissa@gilmartinir.com.

This page (NASDAQ:ZIMV) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -